Ratings CJ Cheiljedang Corporation

Equities

A097950

KR7097950000

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-04-22 pm EDT			5-day change	1st Jan Change
341,500 ^KRW	-1.59%		+2.71%	+5.40%

Apr. 08	Korean Food Companies Boost R&D as Ramyun, Dumplings Gain Popularity	MT
Feb. 29	CJ Cheiljedang Files 20 Million Yuan Patent Case Against Star Lake Bioscience's Unit	MT

Summary

The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

The company's attractive earnings multiples are brought to light by a P/E ratio at 10.07 for the current year.
The company is one of the most undervalued, with an "enterprise value to sales" ratio at 181.56 for the 2024 fiscal year.
The company's share price in relation to its net book value makes it look relatively cheap.
Given the positive cash flows generated by its business, the company's valuation level is an asset.
Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Analyst opinion has improved significantly over the past four months.
Over the past twelve months, analysts' opinions have been strongly revised upwards.
The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.

Weaknesses

The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
Low profitability weakens the company.
The company is not the most generous with respect to shareholders' compensation.
For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
The group usually releases earnings worse than estimated.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Food Processing

	1st Jan change	Capi.	ESG Refinitiv
CJ CHEILJEDANG CORPORATION	+5.40%	3.84B	B
NESTLÉ S.A.	-3.33%	270B	A-
MONDELEZ INTERNATIONAL, INC.	-2.31%	93.37B	C+
KRAFT HEINZ	+3.00%	46.38B	C+
DANONE	+1.57%	40.95B	B-
GENERAL MILLS, INC.	+8.72%	40.18B	B-
THE HERSHEY COMPANY	+0.36%	38.05B	B-
NESTLÉ INDIA LIMITED	-6.02%	28.43B	A
ASSOCIATED BRITISH FOODS PLC	+15.38%	23.11B	A-
YIHAI KERRY ARAWANA HOLDINGS CO., LTD	-10.01%	22.86B	A

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes